The FDAnews Webinar Training Pass program offers year-round, unrestricted access to any of the hundreds of webinars listed below. These training programs feature thought leadership and best practices from top consultants, expert speakers and current and former FDA officials. New webinars are offered every month, along with access to the Webinar Training Pass archive.
BUY NOW Single-User 1-Year Unlimited Access $1,362
If you are already a Training Pass member, login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video, click the "Download Presentation" link.
Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Russ Titsch, Business Development Director at russ.titsch@wcgclinical.com or +1 703.538.7651 to receive a custom quote.
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
- Devising and maintaining a system of internal accounting controls sufficient to provide reasonable assurances that transactions are properly authorized and all amounts are recorded accurately;
- Understanding that the recordkeeping requirements cover all payments, not just those that would be “material” under other accounting requirements; and
- How a company can be in violation of the FCPA’s recordkeeping requirements even if it did not intend to break the law or to keep inaccurate books and records.
Presentation: Download the presentation
Speakers: Keith Korenchuk, Partner, Arnold & Porter, LLP and Samuel Witten, Counsel, Arnold & Porter, LLP
- Consider software for creating/routing/uploading disclosure records;
- Verify new informed consent letters for applicable clinical trials; and
- Adjust compliance strategies for international trials for which the researcher is the sponsor/responsible party.
Presentation: Download the presentation
Speaker: Barbara Godlew, RN, BA, President, The FAIRE Company, LLC
- Number of consignees notified of the recall, and date and method of notification;
- Number of consignees responding to the recall communication and quantity of products on hand at the time it was received;
- Number of consignees that did not respond; and
- Number of products returned or corrected by each consignee contacted and the quantity of products accounted for.
Presentation: Download the presentation
Speaker: James M. Wood, Attorney, Reed Smith
- The ins and outs of when to respond;
- When not to respond; and
- What evidence is most effective with the FDA.
Presentation: Download the presentation
Speaker: Dr. Darshan Kulkarni, Principal Attorney, Kulkarni Law Firm
- Retrospective Case-Control;
- Retrospective Cohort;
- Crossover; and
- Randomized Control Trials.
Presentation: Download the presentation
Speaker: Dr. Debbie Wilkerson, Clinical Research Director, Medtronic Spinal
- Roles and responsibilities for personnel involved in inspections;
- How to greet inspectors and assemble the war room team; and
- When to call on outside experts for help.
Presentation: Download the presentation
Speaker: Dr. Darshan Kulkarni, Principal Attorney, Kulkarni Law Firm
- Intervention trials using prospective and systematic measurement of suicidality that more clearly delineate the relationship between suicidal adverse events and medication treatment;
- Consistent and systematic assessment that provide more meaningful data within a study, as well as across studies, improving pooled analyses;
- Understanding that decreasing false positives and debunking false notions of risk are as important as knowing about risks that exist; and
- Including suicidal subjects in trials to increase generalizability and avoid unnecessary exclusions.
Presentation #1: Download the presentation from Dr. Kelly Posner
Presentation #2: Download the presentation from Dr. John Greist
Speakers: Dr. Kelly Posner, Founder, Center for Suicide Risk Assessment at Columbia University/New York State Psychiatric Institute; Dr. John Greist, CEO, Healthcare Technology Systems and Mike Federico, Vice President, ePRO solutions, ERT Inc.
- How is system access controlled?
- Is there a robust back-up process?
- What is the process for sites if the system is down or the Internet is not available at the time you are obtaining consent from a patient?
Presentation: Download the presentation
Speakers: Dr. Susan Brink, President and CEO, Consent Solutions Inc. and Sherri Bracy, Founder and Director, Bracy Consulting LLC.
- Why large software modules more likely to fail;
- How to assess the amount, quality of testing;
- How to assess the skill and experience level of a designer – when to put the best designers on the most critical software; and
- How to assess the skill and experience level of testers.
Presentation: Download the presentation
Speaker: Dr. David Vogel, Founder, Intertech Engineering Associates
- Misunderstanding the purpose of a quality system;
- Misunderstanding regulatory requirements of the market; and
- Failing to understand that quality is a department, not an integrated practice.
Presentation: Download the presentation
Speaker: Brian Dense, President, CiNQ Systems